Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Lipari Mining (N.LML) Announces Q1-2025 Production and Sales Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Harrow Inc HROW

Healthcare Biotechnology
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America... see more

Recent & Breaking News (NDAQ:HROW)

Harrow Health Shareholder Notice

Newsfile March 17, 2023

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM

PR Newswire March 17, 2023

Harrow Health Shareholder Action Reminder

Newsfile March 15, 2023

Harrow Health Investor Alert

Newsfile March 14, 2023

Harrow Health Shareholder Notice

Newsfile March 13, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow Health, Inc. - HROW

PR Newswire March 13, 2023

Harrow Announces Transitional Pass-Through Reimbursement Status for IHEEZO(TM) (Chloroprocaine Hydrochloride Ophthalmic Gel) 3%

Business Wire March 13, 2023

HARROW HEALTH SHAREHOLDER ACTION REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

PR Newswire March 11, 2023

Harrow Health Shareholder Action Reminder

Newsfile March 10, 2023

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM

PR Newswire March 10, 2023

Harrow Health Investor Alert

Newsfile March 8, 2023

Harrow Health Shareholder Action Reminder

Newsfile March 6, 2023

Harrow Announces Appointment of Mark Mannebach, Ph.D., R.Ph. as Head of Regulatory Affairs and Pharmacovigilance

Business Wire March 6, 2023

HARROW HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

PR Newswire March 4, 2023

ROSEN, A Top Ranked Law Firm, Encourages Harrow Health, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM

Newsfile March 3, 2023

Harrow Health Shareholder Action Reminder

Newsfile March 2, 2023

ROSEN, LEADING INVESTOR COUNSEL, Encourages Harrow Health, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM

PR Newswire March 2, 2023

Harrow to Announce Fourth Quarter 2022 Financial Results on March 23, 2023

Business Wire March 2, 2023

Harrow Health Investor Alert

Newsfile March 1, 2023

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Harrow Health, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile March 1, 2023